Maintenance infliximab (Remicade) is safe, effective and steroid-sparing in Crohn's disease: Preliminary results from the accent i trial
- 1 April 2001
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 120 (5) , A21
- https://doi.org/10.1016/s0016-5085(01)80101-3
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: